Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology</title>
<author><name sortKey="An, Fei Fei" sort="An, Fei Fei" uniqKey="An F" first="Fei-Fei" last="An">Fei-Fei An</name>
<affiliation><nlm:aff id="A1">Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, 413 E 69th St, New York, NY, 10065</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Chan, Mark" sort="Chan, Mark" uniqKey="Chan M" first="Mark" last="Chan">Mark Chan</name>
</author>
<author><name sortKey="Kommidi, Harikrishna" sort="Kommidi, Harikrishna" uniqKey="Kommidi H" first="Harikrishna" last="Kommidi">Harikrishna Kommidi</name>
</author>
<author><name sortKey="Ting, Richard" sort="Ting, Richard" uniqKey="Ting R" first="Richard" last="Ting">Richard Ting</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">27223168</idno>
<idno type="pmc">4958516</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958516</idno>
<idno type="RBID">PMC:4958516</idno>
<idno type="doi">10.2214/AJR.16.16181</idno>
<date when="2016">2016</date>
<idno type="wicri:Area/Pmc/Corpus">003702</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003702</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology</title>
<author><name sortKey="An, Fei Fei" sort="An, Fei Fei" uniqKey="An F" first="Fei-Fei" last="An">Fei-Fei An</name>
<affiliation><nlm:aff id="A1">Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, 413 E 69th St, New York, NY, 10065</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Chan, Mark" sort="Chan, Mark" uniqKey="Chan M" first="Mark" last="Chan">Mark Chan</name>
</author>
<author><name sortKey="Kommidi, Harikrishna" sort="Kommidi, Harikrishna" uniqKey="Kommidi H" first="Harikrishna" last="Kommidi">Harikrishna Kommidi</name>
</author>
<author><name sortKey="Ting, Richard" sort="Ting, Richard" uniqKey="Ting R" first="Richard" last="Ting">Richard Ting</name>
</author>
</analytic>
<series><title level="j">AJR. American journal of roentgenology</title>
<idno type="ISSN">0361-803X</idno>
<idno type="eISSN">1546-3141</idno>
<imprint><date when="2016">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>OBJECTIVE</title>
<p id="P1">The purpose of this article is to summarize advances in PET fluorescence resolution, agent design, and preclinical imaging that make a growing case for clinical PET fluorescence imaging.</p>
</sec>
<sec id="S2"><title>CONCLUSION</title>
<p id="P2">Existing SPECT, PET, fluorescence, and MRI contrast imaging techniques are already deeply integrated into the management of cancer, from initial diagnosis to the observation and management of metastases. Combined positron-emitting fluorescent contrast agents can convey new or substantial benefits that improve on these proven clinical contrast agents.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">7708173</journal-id>
<journal-id journal-id-type="pubmed-jr-id">377</journal-id>
<journal-id journal-id-type="nlm-ta">AJR Am J Roentgenol</journal-id>
<journal-id journal-id-type="iso-abbrev">AJR Am J Roentgenol</journal-id>
<journal-title-group><journal-title>AJR. American journal of roentgenology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0361-803X</issn>
<issn pub-type="epub">1546-3141</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">27223168</article-id>
<article-id pub-id-type="pmc">4958516</article-id>
<article-id pub-id-type="doi">10.2214/AJR.16.16181</article-id>
<article-id pub-id-type="manuscript">NIHMS791904</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>An</surname>
<given-names>Fei-Fei</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Chan</surname>
<given-names>Mark</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Kommidi</surname>
<given-names>Harikrishna</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Ting</surname>
<given-names>Richard</given-names>
</name>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>
Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, 413 E 69th St, New York, NY, 10065</aff>
<author-notes><corresp id="CR1">Address correspondence to R. Ting (<email>rct2001@med.cornell.edu</email>
).</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>3</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub"><day>25</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub"><month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>01</day>
<month>8</month>
<year>2016</year>
</pub-date>
<volume>207</volume>
<issue>2</issue>
<fpage>266</fpage>
<lpage>273</lpage>
<pmc-comment>elocation-id from pubmed: 10.2214/AJR.16.16181</pmc-comment>
<abstract><sec id="S1"><title>OBJECTIVE</title>
<p id="P1">The purpose of this article is to summarize advances in PET fluorescence resolution, agent design, and preclinical imaging that make a growing case for clinical PET fluorescence imaging.</p>
</sec>
<sec id="S2"><title>CONCLUSION</title>
<p id="P2">Existing SPECT, PET, fluorescence, and MRI contrast imaging techniques are already deeply integrated into the management of cancer, from initial diagnosis to the observation and management of metastases. Combined positron-emitting fluorescent contrast agents can convey new or substantial benefits that improve on these proven clinical contrast agents.</p>
</sec>
</abstract>
<kwd-group><kwd>cancer</kwd>
<kwd>contrast medium</kwd>
<kwd>fluorescence</kwd>
<kwd>multimodality imaging</kwd>
<kwd>PET</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 0037029 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 0037029 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Corpus |type= RBID |clé= |texte= }}
![]() | This area was generated with Dilib version V0.6.31. | ![]() |